A high-dose, accelerated escalation schedule during subcutaneous allergen-specific immunotherapy (AIT) is safe and well-tolerated in adults. However, there are no data in children and adolescents. The

NIAID Data Ecosystem30

Baseline characteristics of children by treatment group.

儿童临床试验

营养健康评估

Data are n (%) unless otherwise indicated.*WHO new (2006) growth standard;†MUAC: Mid upper arm circumference;‡BCG: Bacille Calmette Guerin.§ALRI: Acute lower respiratory tract infection;¶RBP: Retinol

Figshare2015-12-02 更新10

Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial

手足口病药物疗效

儿童临床试验

Background No specific antiviral agent against hand foot and mouth disease (HFMD) is available for clinical practice today. Objective To evaluate the efficacy and safety of Jinzhen oral solution in tr

NIAID Data Ecosystem40

Safety of the Malaria Vaccine Candidate, RTS,S/AS01 E in 5 to 17 Month Old Kenyan and Tanzanian Children

疫苗安全性

儿童临床试验

The malaria vaccine candidate, RTS,S/AS01E, showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerabilit

NIAID Data Ecosystem20

Characteristics and comparability of children enrolled into the two arms of the study.

资源简介：

相关数据集